Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

0.3585
-0.0086-2.34%
Volume:298.96K
Turnover:107.13K
Market Cap:14.72M
PE:-0.18
High:0.3699
Open:0.3567
Low:0.3467
Close:0.3671
52wk High:2.60
52wk Low:0.2382
Shares:41.06M
Float Shares:33.92M
Volume Ratio:0.16
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0300
EPS(LYR):-2.7049
ROE:-53.47%
ROA:-8.93%
PB:0.23
PE(LYR):-0.13

Loading ...

Scienture wins US patent for REZENOPY naloxone nasal spray, protection through 2041

Reuters
·
Jun 02

Scienture Receives U.S. Patent Covering Rezenopy™ (Naloxone Hcl) Nasal Spray 10 Mg, Strengthening Intellectual Property Protection Through 2041

THOMSON REUTERS
·
Jun 02

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

GlobeNewswire
·
Jun 02

BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026

Reuters
·
May 30

Scienture - Appoints Narasimhan Mani as Interim CFO Effective May 26, 2026 - SEC Filing

THOMSON REUTERS
·
May 30

Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns

Reuters
·
May 30

Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady

Reuters
·
May 18

Scienture Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

THOMSON REUTERS
·
May 18

Scienture Holdings, Inc Q1 Gross Profit USD 54 Thousand

THOMSON REUTERS
·
May 18

Scienture Holdings, Inc Q1 Operating Expenses USD 3.56 Million

THOMSON REUTERS
·
May 18

SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

GlobeNewswire
·
May 18

Scienture Holdings Q1 EPS $(0.08) Beats $(0.22) Estimate, Sales $56.325K Up From $10.258K YoY

Benzinga Earnings
·
May 16

Scienture net loss widens 11% to $3.4 million in Q1 FY26

Reuters
·
May 16

Scienture Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
May 16

Scienture Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
May 09

BRIEF-Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development Pipeline

Reuters
·
May 07

Scienture secures $11 million non-dilutive debt financing from institutional investor

Reuters
·
May 07

Scienture Holdings - Enters Definitive Agreement With Summit Biosciences for Exclusive U.S. Rights to Commercialize Rezenopy

THOMSON REUTERS
·
May 07

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

GlobeNewswire
·
May 07

Scienture announces third patent granted for Arbli

TIPRANKS
·
May 07